AI-generated summary
This review examines quantum computing, quantum sensing, and quantum nanotechnologies for drug discovery, and extends its scope to device-based therapies including photobiomodulation. The authors report that quantum computing remains mainly hypothesis-generating, while quantum sensing and device platforms with established clinical evidence have more near-term translational value. They stress that claimed quantum advantage often lacks standardized benchmarks and classical comparisons.
- Limits stated in the abstract
- The abstract describes a narrative review and does not report a quantitative evidence synthesis or included study count.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on dovepress.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Neuromodulation, Transcranial direct current stimulation, Transcranial magnetic stimulation, Transcranial photobiomodulation, Light-emitting diode, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.